Suppr超能文献

β-肾上腺素能受体阻断对长时间运动期间体温调节的影响。

Effect of beta-adrenoceptor blockade on thermoregulation during prolonged exercise.

作者信息

Gordon N F, Krüger P E, Van Rensburg J P, Van der Linde A, Kielblock A J, Cilliers J F

出版信息

J Appl Physiol (1985). 1985 Mar;58(3):899-906. doi: 10.1152/jappl.1985.58.3.899.

Abstract

The effect of clinically used equipotent doses of nonselective (beta 1/beta 2; propranolol) and selective (beta 1; atenolol) beta-adrenoceptor blockers on thermoregulation was studied during prolonged exercise in the heat. Oral propranolol (160 mg/day), atenolol (100 mg/day) or matching placebo were taken for 6 days each by 11 healthy young adult caucasian males. Subjects participated in 2 h of block-stepping at a work rate of 54 W in an environmental chamber with a temperature of 33.2 +/- 0.3 degree C dry bulb and 31.7 /+- 0.3 degree C wet bulb, 2 h after ingestion of the final dose of each drug. Both active agents produced similar marked (P less than 0.001) increases in subjective perception of effort, the mechanism of which was not immediately evident from changes in serum electrolytes, blood glucose, blood lactate, or ventilatory parameters. Propranolol did, however, cause a greater rise in serum K+ than placebo (P less than 0.02) and atenolol (P = NS) after exercise. Although rectal and mean skin temperatures were insignificantly altered by beta-adrenoceptor blockade, an increased total sweat production was noted with propranolol (P less than 0.01 vs. placebo) and to a lesser degree atenolol (P = NS vs. placebo) therapy. Analysis of the time course of sweat production showed the propranolol-mediated enhancement of sweating to ensue largely during the initial hour of block-stepping and to be transient in nature. The scientific and clinical implications of this observation will be dependent upon the precise underlying mechanism, a factor not identified by the present study.

摘要

研究了临床上使用的等效剂量的非选择性(β1/β2;普萘洛尔)和选择性(β1;阿替洛尔)β-肾上腺素能受体阻滞剂在热环境中长时间运动期间对体温调节的影响。11名健康的年轻成年白种男性每人分别服用口服普萘洛尔(160毫克/天)、阿替洛尔(100毫克/天)或匹配的安慰剂,各持续6天。在摄入每种药物的最后一剂2小时后,受试者在温度为干球33.2±0.3℃、湿球31.7±0.3℃的环境舱中以54瓦的工作速率进行2小时的阶梯式踏步运动。两种活性药物均使主观努力感显著增加(P<0.001),从血清电解质、血糖、血乳酸或通气参数的变化中,其机制并不立即明显。然而,运动后普萘洛尔确实比安慰剂(P<0.02)和阿替洛尔(P=无显著差异)使血清钾升高幅度更大。虽然β-肾上腺素能受体阻滞剂对直肠温度和平均皮肤温度的改变不显著,但普萘洛尔治疗时总出汗量增加(与安慰剂相比P<0.01),阿替洛尔治疗时出汗量增加程度较小(与安慰剂相比P=无显著差异)。对出汗时间过程的分析表明,普萘洛尔介导的出汗增强主要在阶梯式踏步运动的最初一小时内出现,且本质上是短暂的。这一观察结果的科学和临床意义将取决于确切的潜在机制,而本研究未确定这一因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验